A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)
Clinical trial NCT06794541 · RECRUITING
Trial details
- NCT number
- NCT06794541
- Sponsor
- Tetraphase Pharmaceuticals, Inc
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-22
- Primary completion
- 2029-02-17
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.